ArticleAnalytica chimica acta2025
Evaluation of single-cell heterogeneity and invasive potential in cancer cells via secreted protease activity assay.
Article in Analytica chimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology.Materials today. Bio · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThis paper presents an assay for the secreted protease activity of single cancer cells isolated within chambers of a microfluidic array. The methodology builds on the dielectrophoresis and bipolar electrode (DEP-BPE) platform, enabling live-cell secretion analysis following selective, label-free DEP-based cell isolation. While many existing assays rely on population-level measurements or labeling strategies, there remains a critical need for label-free, functional tools that capture heterogeneity in live-cell secretion behavior at the single-cell level.
resultsThe reported workflow allows for quantification of protease secretion behavior among individual cells, acquisition of temporal secretion profiles, and identification of highly invasive cells. Specifically, we assess the matrix metalloprotease 9 (MMP9) secretion of isolated cancer cells and report substantial heterogeneity in both secreted MMP9 concentration and secretion dynamics at the single-cell level. A linear fluorescence response (R SIGNIFICANCE: This platform enables functional single-cell analysis of invasive potential, providing insights into cellular heterogeneity that are critical for evaluating disease progression and treatment response. The novelty of this work lies in its integration of single-cell isolation by DEP, which is selective for cell type, with a functional assay for a secreted enzyme. The approach is generalizable to selective isolation and molecular assay of many cell types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.